Regulatory Affairs Management

MMS regulatory affairs managers can act as a seamless extension of your regulatory affairs teams.

In addition to providing regulatory strategy consulting, these resources can be assigned as an actual product lead or a lead for a specific submission type.

Regulatory Affairs Management

MMS Regulatory Affairs Managers are an extension of Sponsor regulatory affairs teams. They are assigned to specific products and applications and work with Sponsor teams to execute regulatory activities and facilitate optimal progress/development. 

    Agency Representation and Regulatory Program Management

    In addition to providing regulatory strategy consulting, these regulatory affairs managers are assigned as the actual product lead or lead for a specific submission type.  Team members are responsible for 

    • communication of regulatory requirements and provision of status updates to stakeholders in the Sponsor company
    • development of Module 1 content required for health authority interactions
    • review of required regulatory documentation and files created by other functional lines
    • representation to and interactions with the health authority(ies) on behalf of the Sponsor
    Regulatory Affairs Submission Lead

    Leads the team in the preparation and execution of large and/or complex dossiers 

    Module 1 as a Service

    Regulatory Affairs Managers and Strategists can create regional, Module 1 documentation and provide the team with guidance on the content and format needed to support key interactions with global Health Authorities. 

    Speak with a Regulatory expert

    Learn More With These Insights

    Webinar

    Rare Disease Research in the United States: Understanding FDA Guidance and the Flexible

    Rare Disease Research in the United States: Understanding FDA Guidance and the Flexible

    Blog

    New FDA Guidance to Support Ultra-Rare Disease Drug Development

    How to Get an FDA Orphan Drug Designation

    Blog

    FDA Expedited Program Designations to Support Rare Disease Drug Development

    FDA Expedited Program Designations to Support Rare Disease Drug Development

    Data Management
    & Biostatistics

    Regulatory
    & Medical Writing

    Drug Safety
    & Pharmacovigilance

    Quality & Compliance 
    Services

    TRANSPARENCY SERVICES

    Transparency
    Services


    6880 Commerce Blvd.
    Canton, MI 48187 USA
    734.245.0310 T
    734.245.0320 F

    CONNECT WITH US